Transcript Highlights:

• affect more than 130,000 people in this state who have Parkinson's, plus many other people with neurological
• disorders.
• So we're here requesting... ...people with neurological disorders.

Summary: The Assembly Appropriations Committee met on June 24, 2026, but initially lacked a quorum and began by hearing presentations only. SB 308 was presented as a bill to streamline fiscal reporting for California community colleges by combining two overlapping annual audit reports into one. SB 895, the California Science and Health Research Bond, drew extensive testimony from the authors and many supporters, who argued it would help offset federal research cuts, protect California’s science infrastructure, support jobs, and preserve life-saving research in areas such as cancer, HIV, Parkinson’s, ALS, climate resilience, and quantum computing. The bill was described as a bond measure that would require a three-party agreement and was sent to suspense. After quorum was established, the committee took up the consent and suspense calendars. Several bills were approved on consent, including SB 308 and a large group of other measures, while the suspense calendar was deemed approved, including SB 895 and other bills listed by the chair. Public comment on SB 895 continued for a long period, with many researchers, students, labor representatives, university officials, and patient advocates speaking in strong support and urging the bill be moved to the floor. The committee also heard SB 1350, which would expand green hydrogen by allowing renewable portfolio standard credits for certain hydrogen use in power generation; the author and supporters said it would help clean energy development, create jobs, and support projects like ARCHES and Element. Later, SB 1306 was presented to align California law with federal exemptions for certain chemical mixtures containing GBL used in semiconductor manufacturing research. The author and SEMI’s representative said the bill would reduce unnecessary regulatory burdens, avoid disrupting semiconductor supply chains, and not change rules for pure GBL. The bill passed out of committee on a roll call vote, with one no vote and one not voting. The hearing then adjourned.

Transcript Highlights:

• Health Association and the California Access Coalition represent mental health and substance use disorder
• Every day I witness the devastating impacts of substance use disorders on individuals and their family
• Again, while we share the author's goal of ensuring individuals suffering from substance use disorder
• While we share the author's goal of ensuring individuals suffering from substance use disorder receive
• . across California, 12 and up are considered to have a substance use disorder across California.

Summary: The Assembly Health Committee met on April 22 and took up a special order of bills focused largely on prior authorization and utilization management in health care. The chair framed the discussion as part of a broader legislative effort to reduce delays and barriers to care, especially in behavioral health, chronic disease management, cancer treatment, and rehabilitation services. AB 384 by Assembly Member Connolly would prohibit prior authorization for inpatient mental health or substance use emergency admissions and related physician care; supporters said it would prevent dangerous delays in crisis care, while insurers and health plans warned about fraud, abuse, and ambiguity around residential treatment facilities. The bill was moved on a due pass as amended motion and passed the committee on a party-line style vote, with Republicans largely absent or not voting. The committee then heard AB 510 by Assembly Member Addis, which would require health plans, upon request, to provide a peer reviewer of the same or similar specialty when a treating provider appeals a prior authorization denial or modification. Supporters argued that specialty-matched review would make appeals fairer and more clinically informed; opponents said the requirement was too rigid and that timelines and electronic submission rules needed changes. After discussion about the need for timely, specialty-specific review, the bill was approved on a due pass as amended motion and placed on call. AB 539 by Assembly Member Schiavo would extend prior authorization approvals to one year or the duration of the physician’s prescribed treatment for chronic conditions; supporters cited repeated denials and treatment interruptions, while opponents raised concerns about overbreadth, fraud, and the need for shorter validity periods. The bill was also passed as amended and placed on call. The committee next considered AB 669 by Assembly Member Haney, which would bar concurrent and retrospective review for the first 28 days of medically necessary substance use disorder treatment and limit prior authorization for related outpatient medications. The bill was presented with a powerful personal story from Ryan Matlock’s mother about her son’s death after an insurer cut off treatment early; supporters said the measure would keep patients in care long enough to stabilize, while opponents argued it would reduce oversight and could allow lower-quality or non-evidence-based care. The bill was moved on a due pass as amended motion and placed on call. Finally, AB 512 by Assembly Member Harabedian would shorten prior authorization response times to 24 hours for urgent requests and 48 hours for non-urgent requests; supporters said delays can worsen outcomes, while opponents warned the timelines were unrealistic and could increase administrative burdens and safety issues. The bill was approved as amended and placed on call. AB 574 by Assembly Member Mark Gonzalez was then heard; it would allow up to 12 medically necessary physical therapy sessions for a new episode of care without prior authorization, with supporters emphasizing stroke and neurological recovery and opponents warning of reduced oversight and unnecessary care. The transcript ends during testimony on AB 574, before final action is shown.

Transcript Highlights:

• All right, we're going to take up tab 18, CS for SB 1668 on Florida birth-related neurological injury
• God forbid more than that, each individual case, we're talking about neurological issues.
• And so after that, I had some... ...had some neurological issues.
• What about the student with an autoimmune disorder?
• What about the student with an autoimmune disorder?

Committee: Senate Rules

Transcript Highlights:

• affect more than 130,000 people in this state who have Parkinson's, plus many other people with neurological
• disorders.
• affect more than 130,000 people in this state who have Parkinson's, plus many other people with neurological
• disorders.

Committee: House Appropriations

Transcript Highlights:

• Sickle cell disease is a life-threatening blood disorder that impacts 100,000 people in this country
• I also have a critical ask that this bill be amended to include all connective tissue disorders, not
• We are one of over 200 different disorders, and for me not to speak on that would be a disservice to
• I was an Ehlers-Danlos syndrome or a connective tissue disorder, and I was permanently injured.
• The reaction left me with neurological damage.

Committee: Joint Joint Committee on Financial Services

Summary: The hearing opened with the Senate and House chairs of the Joint Committee on Financial Services explaining that the day’s agenda would focus on health insurance and other insurance matters, with a large number of witnesses and a request for brief testimony. Legislators were taken out of order to accommodate their schedules, and the committee heard testimony on several bills, including coverage for hair prostheses for alopecia (H. 1223/S. 832), medically necessary oral and dental care for head and neck cancer survivors (H. 1258), modernizing fertility and family-building coverage (H. 715/H. 1190 and related bills), coverage for prosthetic devices to support physical activity for people with limb loss (the “So Everybody Can Move” bill), remediation coverage for home heating oil releases (S. 813/H. 1302), and expanded access to physical therapy for Ehlers-Danlos syndrome (H. 1170). A separate bill on sickle cell care and registry development (S. 788) was also discussed by Senator Liz Miranda. Witnesses largely offered personal stories and expert testimony in support of the bills. Advocates for alopecia coverage described the medical and emotional impact of hair loss, the high cost of quality wigs, and the argument that scalp and facial hair prostheses should be treated like other medically necessary prosthetics. Cancer survivors and supporters of H. 1258 said oral and dental care after head and neck cancer treatment is a quality-of-life issue and often not covered despite major out-of-pocket costs. Fertility specialists, LGBTQ+ advocates, and legislators supporting the modern family-building bills said the current infertility definition is outdated and discriminatory, excluding same-sex couples, people needing donors or gestational carriers, and others with medical barriers to conception. For the limb-loss bill, parents and adults with prosthetic needs stressed that activity-specific prostheses are essential for children and adults to run, swim, play sports, and stay healthy, but are often excluded from coverage. The home heating oil testimony focused on the financial devastation caused by residential oil spills and the need to make spill coverage automatic in homeowners policies. Environmental professionals and homeowners described cleanup costs ranging from tens of thousands to hundreds of thousands of dollars, the strict liability homeowners face, and the fact that many policyholders do not know the rider exists. The insurance industry testified in opposition to the mandatory-coverage approach, arguing for clearer distinctions between first- and third-party coverage, risk-mitigation standards, a delayed effective date, and more emphasis on education and notification rather than mandates. Committee members pressed the industry witness on why agents do not routinely tell customers about the rider and suggested that the issue may require broader disclosure by insurers, agents, and fuel dealers. No votes were taken during the hearing; the committee heard testimony and discussed possible compromise language and future action.

Transcript Highlights:

• factors that contribute to harmful algae blooms and have been linked to health issues, including neurological
• disorders. ...and have been linked to health issues, including neurological disorders and gastrointestinal
• every organ of our bodies, including the central nervous system, has been linked to many different neurological

Committee: Senate Rules

Summary: The Committee on Rules met with a quorum and heard extensive debate on SB 734, which would repeal Florida’s wrongful-death medical malpractice exception that bars certain adult children and parents from recovering noneconomic damages. Senator Yarborough presented the bill as a fairness and accountability measure, while many family members testified in support, describing deaths they believed were caused by medical negligence and arguing the current law denies equal justice. Opponents, including physician and insurer representatives, warned the bill could increase malpractice exposure, premiums, defensive medicine, and physician shortages. The committee also considered two late-filed amendments: Senator Burton’s amendment would make Department of Health investigative findings admissible in court, and Senator Martin’s amendment to that amendment would broaden admissibility/discoverability to additional disciplinary and prior-adverse-incident records and insurance coverage facts. After debate, the Martin amendment was adopted, but the Burton amendment as amended failed on a roll call vote. The committee then reported SB 734 favorably without the amendment. The committee next unanimously reported CS for SB 86 favorably. That bill, by Senator Burgess, expands peer support protections for first responders to include support personnel; there was little debate and several law-enforcement-related organizations indicated support. The committee also took up SB 316 on series limited liability companies. Senator Berman explained that the bill creates rules for series LLCs in Florida, and a late-filed amendment, requested by the Secretary of State, delayed implementation by one year. The amendment was adopted and the bill was reported favorably. Finally, the committee considered CS for CS for SB 384, which requires municipalities seeking to annex state-owned land to notify the relevant county legislative delegation when the first public hearing is advertised. Senator Burton presented the bill briefly, there was no opposition or debate, and the committee proceeded to vote on the measure.

Transcript Highlights:

• signaling at extremely low doses and are associated, as the author mentioned, with reproductive disorders
• can be absorbed from soap into our bodies and have been linked to reduced fertility, asthma, and neurological
• These common ingredients in antibacterial soap are linked to neurological, reproductive, and respiratory

Summary: The Environmental Safety and Toxic Materials Committee met to adopt its rules, establish quorum, and approve a consent calendar of five bills, all sent to the Committee on Appropriations. The committee then heard three measures: AB 638 by Assembly Member Rodriguez on stormwater capture for irrigation of urban public lands; AB 60 by Assembly Member Papin on banning synthetic nitro musks in cosmetics and personal care products; and AB 916 by Assembly Member Lee on restricting certain antibacterial soap ingredients in consumer hand soaps and body washes. AB 638 was presented as a climate and water-supply measure directing the State Water Resources Control Board to develop guidelines for capturing and safely reusing stormwater for irrigation. Supporters, including NRDC and several environmental groups, argued it would reduce potable water use and help move stalled projects forward. The bill drew no opposition and received strong support from committee members, including requests to coauthor. It passed the committee on a due pass motion to Appropriations. AB 60 would ban synthetic nitro musks in cosmetics and personal care products due to health and environmental concerns. Supporters cited endocrine disruption, reproductive harms, persistence in waterways, and international restrictions. The bill passed on a due pass motion to the floor, with one member not voting. AB 916 generated the most debate: supporters said the three targeted antimicrobials offer no added benefit over plain soap, may contribute to health harms and antibiotic resistance, and should be banned in consumer products while exempting health care settings. Opponents argued the ingredients are already under FDA and DTSC review, raised preemption concerns, and warned of costs and impacts on food handling and other uses. After extensive discussion, the committee approved AB 916 on a due pass motion to the Committee on Health, with several no votes.

Transcript Highlights:

• Disorder. Make recommendations to decrease health care and criminal justice costs.
• You know, Disorders, excluding Medicaid.
• Attributed to substance abuse disorders.
• Is cannabis the driving force behind schizophrenia and bipolar disorders?
• She has severe bipolar disorder.

Committee: Senate Health & Human Services

Transcript Highlights:

• I had a tremendous increase in autism, every neurological disease, diabetes, everything.
• I had neurological issues. I didn't know to ask questions.
• I had neurological issues. I have neurological issues. With six more vaccines.
• I had neurological issues. I have neurological issues, tactile issues, that kind of thing.
• medical evaluations to learn that they may have underlying genetic mutations or other metabolic disorders

Bills: S0118 , S0896 , S1690 , S1756

Committee: Senate Appropriations

Summary: The committee first took up CS for SB 896, a school safety bill expanding the Guardian program to public postsecondary institutions. The bill requires active assailant response plans, security risk assessments, threat-management protocols, use of the suspicious activity reporting tool, and allows voluntary participation in Guardian for colleges and universities. A late-file amendment by Senator Polsky was adopted to clarify that students who are also employees or faculty are not eligible for Guardian. Members debated campus carry concerns, storage of firearms, and whether the bill could lead to broader gun access on campuses. Several faculty and gun-safety advocates testified against the bill, while supporters argued trained guardians can deter violence. The committee reported the bill favorably by roll call vote. The committee then approved CS for CS for CS for SB 1690 on child care and early learning services. The bill updates child care laws, clarifies regulations, and reduces overregulation of before- and after-school programs. An amendment expanded authority for the Florida Education Foundation to fundraise for early learning from birth to VPK. Testimony was largely supportive, emphasizing affordability, access to quality child care, and relief for working families, though one speaker opposed the bill as an expansion of government. The bill was reported favorably. Next, the committee passed CS for CS for SB 118, which clarifies how non-ad valorem special assessments are applied to recreational vehicle parks and limits the square footage used for assessment purposes to the maximum size of an RV space. The committee also approved CS for CS for SB 1220, the Department of Transportation package, which addresses seaport and airport planning, personal delivery devices, autonomous vehicles, advanced air mobility, toll programming, and other transportation-related changes. Amendments modified provisions on personal delivery devices, utility permits, autonomous vehicle penalties, and law-enforcement cruiser lights. Both bills were reported favorably. Finally, the committee began hearing SB 1756, the medical freedom bill, which proposes new vaccine information requirements, conscience-based school immunization exemptions, limits on compelled vaccination during public health emergencies, and behind-the-counter access to ivermectin for adults. The sponsor and supporters framed the bill as strengthening informed consent and parental rights, while opponents and some senators raised concerns about vaccine hesitancy, herd immunity, and the inclusion of ivermectin. Public testimony was extensive and sharply divided. The transcript ends during continued testimony and debate on SB 1756, before a final vote is taken.

Transcript Highlights:

• , post-traumatic stress disorder.
• and police officers and other folks who have worn the uniform about their post-traumatic stress disorder
• Looking at anxiety disorder, and others. So very exciting news. So recently, Mr.
• But let's say that this did become a mainstream drug for the treatment of psychiatric disorders.
• , with or without psychosis, generalized anxiety disorder, and PTSD.

Summary: The Senate Ad Hoc Committee on Access to Breakthrough Mental Health Therapies met to discuss psychedelic-assisted treatments for serious mental health conditions, with a focus on psilocybin, ibogaine, MDMA, and related compounds. The chair framed the issue as a clinical and access problem for veterans, first responders, and others with PTSD, depression, TBI, addiction, and suicidal ideation, emphasizing that these therapies are intended for supervised medical settings rather than take-home use. Members reviewed research claims and policy trends, including FDA breakthrough therapy designations, state-level psychedelic legislation, and the role of Arizona’s right-to-try law in expanding access once federal approval is in place. Testimony came from Alan Mullen, a retired Army Special Forces veteran, who described his PTSD/TBI history and said ibogaine treatment helped him confront trauma and showed promise in reducing symptoms under strict medical monitoring. Dr. Sue Cisley of Scottsdale Research Institute described ongoing FDA-controlled trials in Arizona, said current medications often fail high-need patients, and urged removal of research barriers and preparation for right-to-try and expanded access. Dan Freiberg of the Professional Firefighters of Arizona said firefighters face chronic exposure to trauma, often rely on alcohol or other coping mechanisms, and need effective alternatives beyond traditional therapy. Dr. Chung Trin discussed late-stage psychedelic trials, the FDA breakthrough pathway, safety oversight, and the need for state readiness when approvals occur. Committee members asked about how the treatments work, whether they require psychotherapy support, safety concerns including suicidality and black-market abuse, patenting and synthetic versus natural versions, and costs compared with ketamine and other treatments. Witnesses said the therapies are administered with extensive screening, monitoring, and integration support, and argued that addiction potential appears low under medical supervision. The discussion ended with interest in sending correspondence to federal officials to support right-to-try cooperation and in continuing the research and policy work; no formal vote or action was taken in the portion provided.

Transcript Highlights:

• , post-traumatic stress disorder.
• and police officers and other folks who have worn the uniform about their post-traumatic stress disorder
• Looking at anxiety disorder, and others. So very exciting news. Recently, Mr.
• But let's say that this did become a mainstream drug for the treatment of psychiatric disorders.
• , with or without psychosis, generalized anxiety disorder, and PTSD.

Summary: The Senate Ad Hoc Committee on Access to Breakthrough Mental Health Therapies held an informational hearing focused on psychedelic-assisted treatments for PTSD, depression, addiction, and related conditions, especially for veterans, first responders, and firefighters. The chair framed the issue as a response to long-standing barriers created by Schedule I restrictions and stigma, emphasizing that the committee was looking at supervised clinical use rather than take-home drugs. Members discussed the growing number of state psychedelic policy proposals, the federal breakthrough therapy pathway, and the idea of Arizona preparing for FDA approval and possibly sending correspondence to federal officials in support of expanded access and Right to Try implementation. Witnesses included retired Army Special Forces Master Sgt. Alan Mullen, who described participating in an ibogaine study for PTSD/TBI and said the treatment, combined with preparation and integration support, helped him confront trauma and showed promise under strict medical monitoring. Dr. Sue Sisley of Scottsdale Research Institute testified that her team is conducting FDA-controlled psychedelic trials, including psilocybin research funded by Arizona, and argued that these therapies can produce major symptom relief with limited doses when delivered in controlled settings. She also urged the legislature to help remove barriers to research and access, including support for Right to Try and possible federal action to allow controlled-substance access. Dan Freiberg of the Professional Fire Fighters of Arizona said firefighters face chronic mental health exposure and often lack effective options beyond traditional therapy or, in some cases, ketamine, and he supported any safe, effective treatment that could help members return to work and reduce suicide risk. Dr. Chung Trin, a mental health physician and trial investigator, explained the FDA breakthrough designation process, said several psychedelic treatments are in late-stage review, and stressed the need for Arizona to build clinical infrastructure so patients can access approved therapies quickly and safely once federal approval occurs. Committee members asked about safety, addiction potential, suicide risk, costs, patents, and whether natural versus synthetic versions of compounds like psilocybin would be available; the hearing ended with general support for continued research, possible legislative correspondence to federal officials, and no formal vote or bill action taken.

Transcript Highlights:

• I specialize in the diagnosis and treatment of brain and learning disorders.
• got worse, she developed an eating disorder, was hospitalized for three weeks, and was placed into a
• He has a lot of learning disorders.
• I myself have a clotting disorder and I was told not to get the COVID vaccine.
• This should concern every parent, every lawmaker, and every person. ...neurological impact.

Committee: Joint Joint Committee on Public Health

Summary: The Joint Committee on Public Health held a hearing on several vaccination-related bills, including proposals to eliminate non-medical or religious exemptions for school immunizations (notably H. 2554 and S. 1557), a bill to require or improve reporting and administration of immunization data and exemptions (described as the Community Immunity Act, S. 1618), and H. 2431, which would prohibit COVID-19, mRNA, or gene-altering vaccine requirements. The committee also heard testimony on H. 2463, which would classify funeral directors as public health workers for vaccine-priority purposes during emergencies. The chair reviewed testimony rules and repeatedly asked speakers to keep comments orderly and brief so the committee could hear as many people as possible. No votes were taken during the hearing. Testimony on H. 2554 and S. 1557 was sharply divided. Pediatricians, infectious disease specialists, public health advocates, and groups such as the Massachusetts Chapter of the American Academy of Pediatrics, Massachusetts Medical Society, March of Dimes, Massachusetts Families for Vaccines, and several parents supported eliminating religious exemptions, arguing that vaccination protects medically vulnerable children and adults, improves herd immunity, and helps prevent outbreaks of measles, pertussis, and other diseases. They cited local school data showing pockets of lower coverage and incomplete reporting, and several speakers referenced outbreaks in other states and the need for stronger, more consistent reporting and exemption management. Opponents argued the bills would infringe on religious freedom and parental rights, force families to choose between faith and education, and unfairly target a small number of families; some also said Massachusetts already has high vaccination rates and that the real issue is incomplete data or the gap population rather than religious exemptions. H. 2431 drew testimony from supporters who said COVID-era mandates caused job losses, privacy concerns, and harm, and that the bill would prevent future requirements for COVID, mRNA, or gene-altering vaccines in schools, workplaces, and public settings. Supporters described personal experiences with alleged vaccine injury or mandate-related hardship. H. 2463 was supported by the Massachusetts Funeral Directors Association, which argued funeral directors work in infection-facing settings and should be eligible for vaccine priority during public health emergencies. The hearing featured extensive public testimony but no committee action beyond hearing the bills and taking questions from members.

Transcript Highlights:

• happens in the early Spectrum Disorder happens in the early 40s<00:27:01.360><c> and</c><00:27:01.640
• </c><00:35:00.839><c> while</c> battling substance use disorder while battling substance use disorder
• </c><00:41:41.599><c> or</c> abuse disorders or abuse disorders or homelessness<00:41:43.640><c> um</
• </c> IR um irre irreversible neurological IR um irre irreversible neurological development<02:49:32.880
• :35.439><c> um</c> development disorders as reported by um development disorders as reported by um the

Summary: The joint hearing opened with House Bill 1462 on crisis services. Testimony from the Department of Law Enforcement, the Community Alliance on Prisons, and the Department of Health supported expanding behavioral health crisis services as an alternative to arrest or incarceration. Witnesses said additional crisis sites would help divert people in mental health crisis to appropriate care, and the Department of Health described its current crisis center in Ewa, including the need for renovations such as a padded room and the time required to get the facility operational. In response to questions, the department estimated the Ewa center’s budgeted cost at about $4.3 million, not including rent or startup repairs, and said a second site’s cost would depend on whether it was freestanding or attached to an existing facility. The committee then heard House Bill 700 on cognitive assessments. The Executive Office on Aging supported the bill’s intent but asked that it be amended to make assessments optional rather than mandated, to pilot the program first, and to allow flexibility in handling HIPAA-protected data. SHPDA also supported the measure but said it should not be mandatory and suggested that payers reimburse for assessments when requested by patients, families, or physicians. The Alzheimer’s Association and caregivers strongly supported standardizing cognitive assessments to improve early detection and access to newer treatments, while noting the existing opt-out provision. The Hawaii State Council on Developmental Disabilities supported the bill but asked that the age 65 threshold be removed because cognitive decline can begin much earlier for people with Down syndrome, autism, traumatic brain injury, stroke, and related conditions. In response to a question, the Office on Aging said a pilot project could likely be done for about $150,000, with data security being the main added cost. The final bill discussed was House Bill 237 on peer support programs. Testimony from Family Hui Hawaii, Early Childhood Action Strategy, peer support workers, and families described peer-to-peer programs as a cost-effective way to reduce isolation, strengthen families, and provide long-term community support. Speakers said these programs help parents and caregivers navigate crises, child welfare involvement, addiction recovery, and other challenges, and can have lasting benefits for children’s development and family stability. Several witnesses tied the bill to broader state goals, including infant and early childhood mental health, trauma-informed care, and child welfare reform. Written testimony from about a dozen organizations and individuals was also noted in support.

Transcript Highlights:

• Then you have children that need to be in an institution because they have a schizophrenic disorder or
• some severe, severe disorder.
• you'll see that those terms and verbiage are kind of focused towards dementia and dementia-related disorders
• The issue with the ADA is that substance abuse disorder is covered by the ADA. It's a disability.
• Neurology care by embedding pharmacists in a 2025 article by a physician, Noah Rosen.

Transcript Highlights:

• disorders, and even cancer.
• disorders, and even cancer.
• </c><00:21:33.039><c> disorders,</c><00:21:33.440><c> and</c> disease, neurological disorders, and disease
• , neurological disorders, and even<00:21:33.840><c> cancer.
• or assess for mental health disorder or assess for mental health disorders<00:27:27.039><c> and</c><

Summary: The House Committee on Public Safety held an informational briefing on the second anniversary of the Maui wildfires, with Chair Dela Alani framing the discussion around emergency preparedness, recovery, and lessons for future disasters. The main presentation came from researchers involved in the Maui Wildfire Exposure Study, who described the project as a grassroots academic-community partnership that has enrolled more than 2,000 adults and children for health screenings, social assessments, and biomonitoring. They said the study has documented elevated mental and physical health conditions, housing instability, unemployment, barriers to care, and exposure to heavy metals and other toxicants, while also noting some modest improvement in adult mental health and self-rated health compared with the prior year. The presenters emphasized that wildfire impacts remain severe two years later. They reported that about half of adult participants had worsening health since the fires, roughly 40% had direct or frequent fire exposure, and many adults showed chronic disease burdens such as hypertension, diabetes, and respiratory impairment. They also said about half of adult survivors reported depressive symptoms, about a quarter had moderate to severe anxiety, more than 4% had considered suicide in the prior month, and nearly one in four had PTSD. A clinician from the Lahaina Certified Community Behavioral Health Center described the clinic’s no-turn-away model, with case management, therapy, psychiatric evaluation, and medication management for anyone who needs it, and urged lawmakers to fund and expand that approach. The researchers also highlighted environmental findings, saying urine testing of more than 1,200 adults found heavy metal signatures that differed between burn-zone residents and those on the perimeter, with higher levels associated with displacement and ash re-exposure. They said about 20% of participants had higher-than-expected heavy metal levels 6 to 12 months after the fires, and cited a negative association between nickel levels and lung function. They argued for long-term monitoring, better cleanup methods, and a centralized health surveillance system tied to community outreach. No vote or formal committee action was taken during the briefing; the chair said the presentation materials and related reports would be posted for public access, and members were invited to ask questions after the presentation.

Transcript Highlights:

• a side effect of certain medications used to treat certain serious mental illnesses like bipolar disorder
• , major depressive disorder, and schizophrenia that often require treatment with antipsychotic medications
• Chair. and the neurological um issues that um and the neurological um issues that um firefighters<03:
• </c> elevated risk of cancer and neurological elevated risk of cancer and neurological disease.<03:32
• These byproducts, these heavy metals, significantly elevated risk of cancer and neurological disease.

Transcript Highlights:

• :26.480><c> subst</c><01:14:27.000><c> substance</c><01:14:27.440><c> abuse</c><01:14:27.760><c> disorder
• </c> years of subst substance abuse disorder years of subst substance abuse disorder uh<01:14:28.520>
• </c><01:15:21.360><c> and</c><01:15:21.760><c> uh</c> and uh psychological neurological and uh and uh
• psychological neurological and uh heart<01:15:22.159><c> related</c><01:15:22.560><c> issues</c><01:
• 29-year-old individual who passed away tragically because she was battling with substance abuse disorder

Bills: HF737 , HF247 , HF325 , HF1330

Committee: House Commerce Finance and Policy

Transcript Highlights:

• Shortly after birth, most babies in the United States are tested for a variety of genetic. disorders
• Specifically, cases where individuals have rare blood types and or suffer from certain blood disorders
• Both girls are born with a rare blood disorder called homozygous beta. thalassemia major.
• surgeries can't bank blood from known friends or family. with sickle cell and other chronic blood disorders
• No child with a red blood disorder like thalassemia or sickle cell is able to get blood from healthy

Bills: SB 53 , SB53 , SB125 , SB315 , SB379 , SB457 , SB541 , SB599 , SB896 , SB921 , SB963 , SB1038 , SB1084 , SB1330 , SB1461

Committee: Senate Health & Human Services

Transcript Highlights:

• It's a rare neurological...” “Lily, who's 26, has Rett syndrome. It's a rare neurological disorder.
• And what we do is we serve the community of people who have substance use disorders, What we do is we
• And the substance use disorders is— ...able to pay taxes, and the substance use disorders impacts Missouri
• She has Rett syndrome, a severe neurological disorder.
• disorders.

Committee: House Budget

Transcript Highlights:

• disorders, and stress-related illnesses.
• Or in children, it could be a sign of a developmental disorder.
• </c> neurologic disease, or systemic illness. neurologic disease, or systemic illness.
• :29:56.120><c> of</c><01:29:56.240><c> a</c><01:29:56.280><c> developmental</c><01:29:57.000><c> disorder
• </c> sign of a developmental disorder. sign of a developmental disorder.

Committee: Senate Health and Human Services